000			01339 a2200385 4500
005			20250515165233.0
264		0	_c20090611
008			200906s 0 0 eng d
022			_a1107-0625
040			_aNLM _beng _cNLM
100	1		_aGrivas, A A
245	0	0	_aImplication of bevacizumab in fatal arterial thromboembolic incidents. _h[electronic resource]
260			_bJournal of B.U.ON. : official journal of the Balkan Union of Oncology _c
300			_a115-7 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAdult
650	0	4	_aAngiogenesis Inhibitors _xadverse effects
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aFatal Outcome
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMaxillary Neoplasms _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aSarcoma _xdrug therapy
650	0	4	_aThromboembolism _xchemically induced
700	1		_aTrafalis, D T
700	1		_aAthanassiou, A E
773	0		_tJournal of B.U.ON. : official journal of the Balkan Union of Oncology _gvol. 14 _gno. 1 _gp. 115-7
999			_c18798102 _d18798102